idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instance:
Share on: 
10/22/2025 12:40

Sharper gene scissors for the biotechnology toolbox

Inka Burow Stabsstelle Kommunikation
Medizinische Hochschule Hannover

    MHH scientists improve three variants of the CRISPR-Cas9 system for more targeted and effective biomedical application.

    The goal of gene therapies is to permanently cure hereditary diseases. One of the most promising technologies for this is the CRISPR/Cas system, colloquially known as gene scissors. These can cut and modify DNA in a targeted manner to repair or remove defective genes or insert new ones. There are different variants of gene scissors, each of which targets specific locations in the genome. However, not all of them are equally efficient, i.e. they do not all cut reliably at the exact location in the DNA where they are supposed to. A research team led by Professor Tobias Cantz and Dr Reto Eggenschwiler from the Department of Gastroenterology, Hepatology, Infectiology and Endocrinology at Hannover Medical School (MHH) has now found a way to sharpen three variants of gene scissors and increase their effectiveness. This adds further functional tools to the biotechnological toolbox. The results of the scientific study were recently published in the renowned journal ´Nucleic Acids Research´

    Origin: bacterial virus defence

    Originally, the CRISPR system was a biological defence mechanism used by bacteria to protect themselves against infection by phages. These are viruses that exclusively attack bacteria. The foreign DNA is destroyed by the gene scissors and the phage can no longer reproduce. Different bacteria have different types and subtypes of these CRISPR systems. The CRISPR/Cas9 system from the bacterium Streptococcus pyogenes, which can cause scarlet fever in humans, among other things, is predominantly used. The system uses a so-called pilot RNA, which, like a biological navigation device, guides the Cas9 enzyme to a specific location in the DNA where it causes a double-strand break. Targeted genetic modifications can then be made at this location. The cell's repair mechanisms later rejoin the double strand.

    In order for Cas9 to become active, it requires a specific DNA recognition motif, a so-called PAM sequence (protospacer-adjacent motif). This is a short nucleotide section on the DNA. Nucleotides are the basic chemical building blocks of our DNA and consist of a sugar, a phosphate group and a nucleic base. There are four different DNA nucleic bases: adenine, guanine, cytosine and thymine. The nucleotides store and transmit our genetic information.

    Cas9 variants cut at other DNA sites

    The PAM nucleotide section on the DNA is required by the Cas9 enzyme to cut the directly adjacent site in the genome. This sequence therefore determines the exact areas that can be edited by the gene scissors. The common PAM sequence of the CRISPR/Cas9 system is NGGN. Here, ‘N’ stands for a variable nucleotide – i.e. one with any of the four bases – which must be followed by two nucleotides with guanine bases. This is followed by another variable nucleotide. However, there are also Cas9 variants that target other PAM sequences or can even largely dispense with PAM recognition. The gene scissors equipped with these variants can therefore cut the genetic material at different sites than the original version. The disadvantage is that they cut less efficiently than the standard CRISPR/Cas9 system. Dr. Eggenschwiler's research team has now investigated the interaction with the DNA of three of these Cas9 variants in detail and then genetically modified them in a targeted manner. ‘We first improved a Cas9 enzyme called iSpyMac, which can be used to specifically target NAAN-PAMs,’ says Dr Eggenschwiler. ‘This is important because “AA” is the most common dinucleotide, i.e. the most common double base sequence in the human genome, and thus opens up many new possibilities for gene modification.’

    Greater efficiency through improved interaction

    Further potential for new interfaces is also offered by improvements to the Cas9-SpRY and Cas9-SpG enzymes. Cas9-SpRY is a so-called PAM-free enzyme, which, unlike standard Cas9, no longer requires a strict PAM sequence. This further development makes it possible to cut and modify DNA at any location. The same applies to Cas9-SpG. This variant targets the NGNN-PAM, meaning it only needs a single guanine nucleotide as a recognition site on the DNA. Both variants can be used to target sites in the genome where no ‘traditional’ NGGN-PAMs are available, which significantly increases the flexibility of CRISPR/Cas9 technology. ‘With the help of AI-generated 3D models and high-performance computer simulations, we were able to identify the relevant important structural areas in the Cas9 variants,’ explains the molecular biologist. ‘We then specifically modified the enzymes in such a way that their interaction with the DNA at some target sites could be increased up to fourfold.’ The improved variants now allow for more effective genetic modifications across the entire genome.

    Goal: treating inherited gene mutations

    With the help of these new enzymes, the researchers now want to repair an inherited gene mutation that causes alpha-1 antitrypsin deficiency. In this disease, the body lacks a protective protein, which damages the lungs and liver. ‘We want to replace this one defective base with the correct variant,’ says Mika Opitz, research assistant and co-author of the study. If successful, this would be another step towards a permanent cure for this serious disease, which requires a lung or liver transplant in its final stage.

    SERVICE

    For further information, please contact Dr Reto Eggenschwiler, eggenschwiler.reto@mh-hannover.de.


    Original publication:

    https://academic.oup.com/nar/article/53/15/gkaf782/8233998


    Images

    Three gene scissors sharpened for research: molecular biologist Dr Reto Eggenschwiler (left) and research assistant Mika Opitz.
    Three gene scissors sharpened for research: molecular biologist Dr Reto Eggenschwiler (left) and res ...
    Source: Karin Kaiser/MHH.


    Criteria of this press release:
    Journalists
    Medicine
    transregional, national
    Research results, Scientific Publications
    English


     

    Three gene scissors sharpened for research: molecular biologist Dr Reto Eggenschwiler (left) and research assistant Mika Opitz.


    For download

    x

    Help

    Search / advanced search of the idw archives
    Combination of search terms

    You can combine search terms with and, or and/or not, e.g. Philo not logy.

    Brackets

    You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).

    Phrases

    Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.

    Selection criteria

    You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).

    If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).